{"schema_version":"secwatch.filing_event.v1","accession":"0001867096-25-000034","form_type":"8-K","ticker":"XERS","cik":"0001867096","company_name":"Xeris Biopharma Holdings, Inc.","filed_at":"2025-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.385075+00:00","generated_at":"2026-05-25T07:34:20.916141+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Xeris Biopharma reports record Q4 revenue $60M (+35% YoY); guides 2025 rev $255M-$275M","bullets":["Record Q4 total revenue $60.1M (+35% YoY); full-year $203.1M (+24% YoY)","Recorlev Q4 revenue $22.6M (+131% YoY); full-year $64.3M (+118% YoY)","Q4 net loss $5.1M (($0.03)/share); Adjusted EBITDA $8.3M; cash $71.6M","FY2025 revenue guidance $255M-$275M; expects positive Adjusted EBITDA going forward"],"urls":{"canonical":"https://secwatch.observer/filing/0001867096-25-000034","json":"https://secwatch.observer/filing/0001867096-25-000034.json","markdown":"https://secwatch.observer/filing/0001867096-25-000034.md","text":"https://secwatch.observer/filing/0001867096-25-000034.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1867096/000186709625000034/0001867096-25-000034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1867096/000186709625000034/xers-20250306.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T07:34:20.916141+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}